HomeInvestingMRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

Shares in drug giant Moderna (MRNA) plummeted nearly 10% today after it reported a drop in Q2 sales.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst in… [2753 chars]

web-interns@dakdan.com

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments